DK1383897T3 - Selv-containing Lactococcus-stamme - Google Patents

Selv-containing Lactococcus-stamme

Info

Publication number
DK1383897T3
DK1383897T3 DK02740565T DK02740565T DK1383897T3 DK 1383897 T3 DK1383897 T3 DK 1383897T3 DK 02740565 T DK02740565 T DK 02740565T DK 02740565 T DK02740565 T DK 02740565T DK 1383897 T3 DK1383897 T3 DK 1383897T3
Authority
DK
Denmark
Prior art keywords
self
survive
lactococcus strain
medium
containing lactococcus
Prior art date
Application number
DK02740565T
Other languages
Danish (da)
English (en)
Inventor
Lothar Steidler
Original Assignee
Vlaams Interuniv Inst Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Interuniv Inst Biotech filed Critical Vlaams Interuniv Inst Biotech
Application granted granted Critical
Publication of DK1383897T3 publication Critical patent/DK1383897T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y201/00—Transferases transferring one-carbon groups (2.1)
    • C12Y201/01—Methyltransferases (2.1.1)
    • C12Y201/01045—Thymidylate synthase (2.1.1.45)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK02740565T 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme DK1383897T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01201631 2001-05-03
EP01204785 2001-12-07

Publications (1)

Publication Number Publication Date
DK1383897T3 true DK1383897T3 (da) 2006-10-30

Family

ID=26076897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740565T DK1383897T3 (da) 2001-05-03 2002-05-03 Selv-containing Lactococcus-stamme

Country Status (9)

Country Link
EP (1) EP1383897B1 (de)
JP (2) JP4347575B2 (de)
AT (1) ATE331789T1 (de)
AU (1) AU2002314040B2 (de)
CA (1) CA2446776C (de)
DE (1) DE60212825T2 (de)
DK (1) DK1383897T3 (de)
ES (1) ES2266515T3 (de)
WO (1) WO2002090551A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
ES2302945T3 (es) 2002-06-19 2008-08-01 Actogenix N.V. Metodos y medios para fomentar la absorcion intestinal.
AU2003303222A1 (en) * 2002-12-19 2004-07-14 Universiteit Gent Mutant proteins showing increased secretion
JP4589618B2 (ja) * 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
ES2439698T3 (es) 2004-08-20 2014-01-24 Actogenix N.V. Procedimiento para mejorar la conservación de lactococos
DK2119450T3 (da) * 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
CA2672229A1 (en) * 2006-12-14 2008-06-19 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
CA2675115C (en) 2007-01-12 2014-12-09 Actogenix N.V. Lactococcus promoters and uses thereof
US20100104601A1 (en) 2007-01-25 2010-04-29 Pieter Rottiers Treatment of immune disease by mucosal delivery of antigents using genetically modified lactobacillus
JP2012504116A (ja) * 2008-09-29 2012-02-16 アクトジェニックス・エヌブイ 粘膜での微生物のコロニー形成の低減
KR102066292B1 (ko) 2011-06-01 2020-01-14 인트랙슨 액토바이오틱스 엔.브이. 박테리아용 폴리시스트론 발현 시스템
US9347036B2 (en) 2011-09-23 2016-05-24 Intrexon Actobiotics Nv Modified gram positive bacteria and uses thereof
ES2676707T3 (es) 2011-09-23 2018-07-24 Intrexon Actobiotics Nv Bacterias gram positivas modificadas y usos de las mismas
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
AU2016226234B2 (en) * 2015-03-02 2022-02-17 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
CN106148254B (zh) * 2015-03-26 2019-11-12 南京华贞生物医药科技有限公司 一种用于减肥降脂的转化体及其构建方法与应用
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
CA3005451A1 (en) 2015-11-16 2017-05-26 Synlogic Operating Company, Inc. Bacteria engineered to reduce hyperphenylalaninemia
US10905727B2 (en) 2016-01-14 2021-02-02 Intrexon Actobiotics N.V. Compositions and methods for the treatment of type 1 diabetes
CN109843320A (zh) 2016-09-02 2019-06-04 英特瑞克斯顿阿克图比奥帝克斯有限公司 稳定表达il-10和胰岛素的遗传修饰的细菌
CN109983028B (zh) 2016-09-13 2023-10-20 英特瑞克斯顿阿克图比奥帝克斯有限公司 黏膜黏附性微生物
EP3864048A1 (de) 2018-10-11 2021-08-18 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Bakterien, die einzelkettige antikörper gegen toll-ähnliche rezeptoren exprimieren
JP2023500563A (ja) 2019-09-27 2023-01-10 イントレキソン アクトビオティクス エヌヴェー デー／ベー／アー プレシゲン アクトビオ セリアック病の治療
IL295353A (en) 2020-03-20 2022-10-01 Synlogic Operating Co Inc Genetically engineered microorganisms to reduce hyperphenylalaninemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4231764A1 (de) * 1992-09-23 1994-03-24 Inst Pflanzengenetik & Kultur Verfahren zur chromosomalen Integration eines Produkt-Gens

Also Published As

Publication number Publication date
JP2009060913A (ja) 2009-03-26
WO2002090551A3 (en) 2003-03-27
EP1383897B1 (de) 2006-06-28
CA2446776C (en) 2011-07-12
ES2266515T3 (es) 2007-03-01
ATE331789T1 (de) 2006-07-15
DE60212825T2 (de) 2007-01-11
WO2002090551A2 (en) 2002-11-14
EP1383897A2 (de) 2004-01-28
JP2004533246A (ja) 2004-11-04
AU2002314040B2 (en) 2007-06-28
DE60212825D1 (de) 2006-08-10
CA2446776A1 (en) 2002-11-14
JP4347575B2 (ja) 2009-10-21

Similar Documents

Publication Publication Date Title
DK1383897T3 (da) Selv-containing Lactococcus-stamme
WO2004046346A3 (en) Self-containing lactobacillus strain
DE60111570D1 (de) Isoindolin-1-on als glukokinaseaktivatoren
CA2318299A1 (en) Metadata exchange
WO2001064835A8 (en) Novel nucleic acids and polypeptides
DE602005022740D1 (de) Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)
WO2005056759A3 (en) Methods of generating variant proteins with increased host string content and compositions thereof
ATE468627T1 (de) Disc-monopol-antennenstruktur
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
EP1308834A3 (de) Intelligente Druckereinstellungen
ITVA20020050A1 (it) Metodo e circuito di amplificazione con pre-enfasi.
SG149058A1 (en) Live genetically attenuated malaria vaccine
DE69923676D1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
DE60006825D1 (de) Serotonerge benzofurane
AU2003245134A1 (en) Oxytocin as cardiomyogenesis inducer and uses thereof
AU2002314098A1 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
RS20060196A (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
MY128306A (en) Oct formulations
DE60227936D1 (de) D-hydantoinase aus ochrobactrum anthropi
DE60224026D1 (de) Rechen
WO2003103130A3 (en) MAGNETRONS
EP1532177A4 (de) Immunmodulatorische konstrukte und deren verwendungen
USD500220S1 (en) Desk top